Kestra Medical Technologi...

NASDAQ: KMTS · Real-Time Price · USD
16.03
0.07 (0.44%)
At close: Aug 15, 2025, 3:46 PM

Kestra Medical Common Stock Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023
Net Income
-113.81M -94.12M -84.24M
Depreciation & Amortization
7.97M 11.56M 4.86M
Stock-Based Compensation
24.27M 1.49M 1.21M
Other Working Capital
3.17M 223K -112K
Other Non-Cash Items
10.11M 4.44M 7.28M
Deferred Income Tax
64K 12K -45K
Change in Working Capital
-6.2M 4.39M 1.3M
Operating Cash Flow
-77.61M -72.23M -69.64M
Capital Expenditures
-23.59M -12.51M -15.46M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
283K 285K n/a
Investing Cash Flow
-23.31M -12.23M -15.46M
Debt Repayment
n/a 5.88M -5.33M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
-1.65M -799K -671K
Other Financial Acitivies
12.73M -2.35M n/a
Financial Cash Flow
330.26M 77.72M 96.11M
Net Cash Flow
229.35M -6.74M 11M
Free Cash Flow
-101.2M -84.75M -85.1M